Baidu
map

上海首家“云医院” 在线问诊配药

2016-04-06 佚名 澎湃新闻网

在2015年8月试运营以来,上海首家“云医院”已拥有6万名注册患者,总共为16万人次市民提供线上服务,接下来还有望开通24小时“云急诊”。澎湃新闻(www.thepaper.cn)记者近日从“2016上海国际慢病管理高峰论坛”获得了上述信息。入院检查可不再挂号预约论坛指出,中国已进入慢性病高负担期,且每年以30%的速度迅速上升。据上海中医药大学校长徐建光介绍,慢性病具有发病率高、患病人数多、治愈率

在2015年8月试运营以来,上海首家“云医院”已拥有6万名注册患者,总共为16万人次市民提供线上服务,接下来还有望开通24小时“云急诊”。澎湃新闻(www.thepaper.cn)记者近日从“2016上海国际慢病管理高峰论坛”获得了上述信息。

入院检查可不再挂号预约

论坛指出,中国已进入慢性病高负担期,且每年以30%的速度迅速上升。

据上海中医药大学校长徐建光介绍,慢性病具有发病率高、患病人数多、治愈率低的特点。2015年8月,中国医疗保健国际交流促进会OTO慢性病综合管理分会正式成立。中国卫生计生委将发布《2016—2025年慢性病防治中长期规划》。

首任OTO慢性病综合管理分会主委、复旦大学附属中山医院院长樊嘉指出,在上海像中山医院这样的大医院,已陷入超负荷运转的困境,慢性病患者占所有诊疗患者的30%至40%,亟须创新医疗问诊模式,“云医院”应运而生。

上海首家“云医院”由复旦大学附属中山医院、徐汇区中心医院、13家社区卫生服务中心以及70家零售药店等联合打造。

据樊嘉介绍,上海市民下载“云医院”APP后,把在社区和中山医院就诊的病史资料开通共享功能,可通过“云医院”在线看医生、接受线上问诊,医生将开具电子处方单。凭这张处方单,病人可以到全市医保定点药店配药,也可以手机直接下单付款,药品将通过快递配送到家。

如果线上问诊时医生认为病人还需进一步检查,凭借在线预约的号码,病人可直接到徐汇区中心医院通过医保卡做一系列检查,不需要重新挂号预约。目前,市民还可以就近在13家社区卫生服务中心的“健康小屋”,先检查血压血象指标,然后通过那里的设备找到“云医生”。

有望开通24小时“云急诊”

目前,徐汇区中心医院有300名医生已注册成为“云医生”,复旦大学附属中山医院一批高年资医生也开始在这一平台上在线为患者提供服务。

会议透露,下一步“云医院”有望开通24小时“云急诊”,与120急救中心签约,急救医生可以通过下载专属客户端,引导患者及时有效就近诊疗。与此同时,“云医院”覆盖范围将会逐步扩大,未来上海对口支援省市、养老机构等或将被纳入。

徐汇区中心医院院长朱福透露,“云医院”试运转半年以来,从起初的高血压一个病种目前已经覆盖到糖尿病、肿瘤等多种慢性病,已有6万市民注册为“云病人”,提供诊疗服务16万人次。

樊嘉表示,为了实现从“云上”到线下的无缝慢性病管理,预计本周中山医院还将牵头成立徐汇片区医疗联合体,彻底打通疑难杂症病人转诊通道。中山医院便民助医“中山关怀”APP也将和“云医院”实现全程对接,让挂号预约检查更便捷。“云医院”即将和市总工会启动全面合作,今后持工会会员卡职工线上问诊免费,线下挂号打九折。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2017-03-14 lhlxtx
  3. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-07 hekzn

    初衷是好的,但是还有许多问题需要解决啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-07 田田1746

    移动医疗市场

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-07 1de07360m07(暂无匿称)

    了解一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 老段

    继续观望

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 wei834766788

    不知道

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 wei834766788

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 wei834766788

    ~~~~…………………………

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2066515, encodeId=34c2206651558, content=<a href='/topic/show?id=77ba413149b' target=_blank style='color:#2F92EE;'>#在线问诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41314, encryptionId=77ba413149b, topicName=在线问诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a5c2500147, createdName=12498bb3m90(暂无昵称), createdTime=Wed Sep 28 14:55:00 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677536, encodeId=68f916e7536bd, content=<a href='/topic/show?id=fed224083d7' target=_blank style='color:#2F92EE;'>#云医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24083, encryptionId=fed224083d7, topicName=云医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ff127540952, createdName=lhlxtx, createdTime=Tue Mar 14 04:55:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76185, encodeId=3733e618571, content=初衷是好的,但是还有许多问题需要解决啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Thu Apr 07 07:49:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76172, encodeId=e2cce617296, content=移动医疗市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Apr 07 06:39:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76159, encodeId=526ee615942, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Thu Apr 07 05:13:00 CST 2016, time=2016-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76086, encodeId=0bc4e608626, content=继续观望, beContent=null, objectType=article, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 06 18:11:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76055, encodeId=1edbe605524, content=不知道, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76056, encodeId=0610e60562b, content=?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76058, encodeId=40dce605868, content=~~~~…………………………, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Wed Apr 06 15:47:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76049, encodeId=0460e60499c, content=运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75fd1301452, createdName=tjzge, createdTime=Wed Apr 06 15:46:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 tjzge

    运营费用谁出?出了医疗纠纷谁负责?如吃了药出现严重副反应

    0

Baidu
map
Baidu
map
Baidu
map